Loading...
Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
Tumor necrosis factor-α (TNF-α) inhibitors are increasingly being used as treatment for rheumatoid arthritis (RA). However, the administration of these drugs carries the risk of inducing injection site reaction (ISR). ISR gives rise to patient stress, nervousness, and a decrease in quality of life (...
Saved in:
| Published in: | Int J Med Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Ivyspring International Publisher
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5332837/ https://ncbi.nlm.nih.gov/pubmed/28260984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.17025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|